Literature DB >> 10419372

Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors.

J E York1, G L Walsh, F F Lang, J B Putnam, I E McCutcheon, S G Swisher, R Komaki, Z L Gokaslan.   

Abstract

OBJECT: Traditionally, superior sulcus tumors of the lung that involve the chest wall and spinal column have been considered to be unresectable, and historically, patients harboring these tumors have been treated with local radiation therapy with, at best, modest results. The value of gross-total resection remains unclear in this patient population; however, with the recent advances in surgical technique and spinal instrumentation, procedures involving more radical removal of such tumors are now possible. At The University of Texas M. D. Anderson Cancer Center, the authors have developed a new technique for resecting superior sulcus tumors that invade the chest wall and spinal column. They present a technical description of this procedure and results in nine patients in whom stage IIIb superior sulcus tumors extensively invaded the vertebral column.
METHODS: These patients underwent gross-total tumor resection via a combined approach that included posterolateral thoracotomy, apical lobectomy, chest wall resection, laminectomy, vertebrectomy, anterior spinal column reconstruction with methylmethacrylate, and placement of spinal instrumentation. There were six men and three women, with a mean age of 55 years (range 36-72 years). Histological examination revealed squamous cell carcinoma (three patients), adenocarcinoma (four patients), and large cell carcinoma (two patients). The mean postoperative follow-up period was 16 months. All patients are currently ambulatory or remained ambulatory until they died. Pain related to tumor invasion improved in four patients and remained unchanged in five. In three patients instrumentation failed and required revision. There was one case of cerebrospinal fluid leakage that was treated with lumbar drainage and one case of wound breakdown that required revision. Two patients experienced local tumor recurrence, and one patient developed a second primary lung tumor.
CONCLUSIONS: The authors conclude that in selected patients, combined radical resection of superior sulcus tumors of the lung that involve the chest wall and spinal column may represent an acceptable treatment modality that can offer a potential cure while preserving neurological function and providing pain control.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419372     DOI: 10.3171/spi.1999.91.1.0074

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Paravertebral primitive neuroectodermal tumour presenting with Horner's syndrome.

Authors:  D N Parmar; N Lim; N Joshi
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Chest wall reconstruction after en bloc Pancoast tumour resection with the use of MatrixRib and SILC fixation systems: technical note.

Authors:  Marcin Czyz; Emmanuel Addae-Boateng; Bronek M Boszczyk
Journal:  Eur Spine J       Date:  2015-07-29       Impact factor: 3.134

3.  Analysis of the surgical treatment for superior sulcus tumors.

Authors:  Yoshinobu Ichiki; Akira Nagashima; Manabu Yasuda; Mitsuhiro Takenoyama
Journal:  Surg Today       Date:  2012-12-02       Impact factor: 2.549

Review 4.  Superior sulcus tumors.

Authors:  C D Wright; D J Mathisen
Journal:  Curr Treat Options Oncol       Date:  2001-02

Review 5.  Superior sulcus tumors (Pancoast tumors).

Authors:  Giuseppe Marulli; Lucia Battistella; Marco Mammana; Francesca Calabrese; Federico Rea
Journal:  Ann Transl Med       Date:  2016-06

6.  Single Posterior Approach for En-Bloc Resection and Stabilization for Locally Advanced Pancoast Tumors Involving the Spine: Single Centre Experience.

Authors:  Fahed Zairi; Tarek Sunna; Moishe Liberman; Ghassan Boubez; Zhi Wang; Daniel Shedid
Journal:  Asian Spine J       Date:  2016-12-08

Review 7.  Current Surgical Indications for Non-Small-Cell Lung Cancer.

Authors:  Nathaniel Deboever; Kyle G Mitchell; Hope A Feldman; Tina Cascone; Boris Sepesi
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.